Titan Biotech Ltd approves Q2 FY27 results, with standalone net profit up 65.1% year on year to ₹1,133.07 lakh
- Q2 standalone revenue rose 31.0% year on year to ₹7,646.25 lakh; estimated operating margin was 17.9%.
- Consolidated net profit was ₹1,254.78 lakh, including ₹121.66 lakh share of profit from associates.
- No exceptional items were reported; auditors’ limited-review conclusions were unmodified.
